CIT chairman discusses LAB takeover
Last week non-clinical CRO CIT bought Canadian counterpart LAB Research. Outsourcing-pharma.com spoke with CIT executive chairman Jean-Francois Le Bigot about the deal and the plan going forward.
Archives for May 4, 2011
INC Research to buy Kendle & aim at top 5 clinical CROs
INC Research is to acquire Kendle in a deal that would give it Phase II to IV clinical assets comparable to those at Covance.
Aptuit producing fast-dissolve nanoparticles in Ph III deal
Aptuit is manufacturing Phase III materials for Iroko using a nanoformulation technology that produces fast-dissolving particles.
AMRI posts small Q1 loss but sees strong growth of manufacturing biz
Albany Molecular Research (AMRI) posted a modest net loss on costs and restructuring charges, but saw revenue grow considerably in the first quarter thanks to contracting business and royalties.
Appointments at CMC Biologics, PharmaNet and AAIPharma – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at CMC Biologics, PharmaNet and AAIPharma.
Quotient Clinical expands ADME capacity
Quotient Clinical has expanded its clinical facility in Nottingham, UK, citing increasing demand for ADME studies.
Merck sells manufacturing operations in South Africa
Merck South Africa, a subsidiary of German pharma giant, Merck KGaA, has sold its Merck Pharmaceutical Manufacturing (MPM) operations in Johannesburg to investment firm, Nkunzi Investment Holdings.